Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Input Field |
Entered |
---|---|
SERIAL NUMBER | 88334351 |
LAW OFFICE ASSIGNED | LAW OFFICE 104 |
MARK SECTION | |
MARK | http://uspto.report/TM/88334351/mark.png |
LITERAL ELEMENT | RHENFOR |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size or color. |
ARGUMENT(S) | |
The Examining Attorney has refused registration citing a duplicate registration, namely Registration No. 4296729. Applicant respectfully submits that Registrant did not file the requisite Declaration of Use and/or Excusable Nonuse under Section 8 prior to the expiration of the six-month grace period on September 5, 2019. As such, the registration will be cancelled in due course. Noting that no other objections have been raised, Applicant respectfully requests approval of the instant application for publication. |
|
ATTORNEY SECTION (current) | |
NAME | Merilee J. Arevalo |
ATTORNEY BAR MEMBERSHIP NUMBER | NOT SPECIFIED |
YEAR OF ADMISSION | NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY | NOT SPECIFIED |
INTERNAL ADDRESS | LBP, 5.5A |
STREET | 5 MOORE DRIVE |
CITY | RESEARCH TRIANGLE PARK |
STATE | North Carolina |
POSTAL CODE | 27709-3398 |
COUNTRY | US |
PHONE | 919-315-8204 |
FAX | 919-315-3023 |
trademarks@gsk.com | |
AUTHORIZED TO COMMUNICATE VIA EMAIL | Yes |
DOCKET/REFERENCE NUMBER | 82771811 |
ATTORNEY SECTION (proposed) | |
NAME | Merilee J. Arevalo |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | GSK |
INTERNAL ADDRESS | LBP, 5.5A |
STREET | 5 MOORE DRIVE |
CITY | RESEARCH TRIANGLE PARK |
STATE | North Carolina |
POSTAL CODE | 27709-3398 |
COUNTRY | United States |
PHONE | 919-315-8204 |
FAX | 919-315-3023 |
trademarks@gsk.com | |
AUTHORIZED TO COMMUNICATE VIA EMAIL | Yes |
DOCKET/REFERENCE NUMBER | 82771811 |
OTHER APPOINTED ATTORNEY | Christopher M. Hanes, Terence A. Dixon and Michele A. Farber |
CORRESPONDENCE SECTION (current) | |
NAME | MERILEE J. AREVALO |
INTERNAL ADDRESS | LBP, 5.5A |
STREET | 5 MOORE DRIVE |
CITY | RESEARCH TRIANGLE PARK |
STATE | North Carolina |
POSTAL CODE | 27709-3398 |
COUNTRY | US |
PHONE | 919-315-8204 |
FAX | 919-315-3023 |
trademarks@gsk.com | |
AUTHORIZED TO COMMUNICATE VIA EMAIL | Yes |
DOCKET/REFERENCE NUMBER | 82771811 |
CORRESPONDENCE SECTION (proposed) | |
NAME | Merilee J. Arevalo |
FIRM NAME | GSK |
INTERNAL ADDRESS | LBP, 5.5A |
STREET | 5 MOORE DRIVE |
CITY | RESEARCH TRIANGLE PARK |
STATE | North Carolina |
POSTAL CODE | 27709-3398 |
COUNTRY | United States |
PHONE | 919-315-8204 |
FAX | 919-315-3023 |
trademarks@gsk.com | |
AUTHORIZED TO COMMUNICATE VIA EMAIL | Yes |
DOCKET/REFERENCE NUMBER | 82771811 |
SIGNATURE SECTION | |
RESPONSE SIGNATURE | /Merilee J. Arevalo/ |
SIGNATORY'S NAME | Merilee J. Arevalo |
SIGNATORY'S POSITION | Trademark Counsel, GSK, New Jersey and Pennsylvania |
SIGNATORY'S PHONE NUMBER | 919-315-8204 |
DATE SIGNED | 10/03/2019 |
AUTHORIZED SIGNATORY | YES |
FILING INFORMATION SECTION | |
SUBMIT DATE | Thu Oct 03 14:18:11 EDT 2019 |
TEAS STAMP | USPTO/ROA-XXX.XX.XX.X-201 91003141811232623-8833435 1-610eb9a9c1ae348456c206a 867a201aac7a17dae6c283a66 af1431da619adf28c6-N/A-N/ A-20191003125550199087 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
The Examining Attorney has refused registration citing a duplicate registration, namely Registration No. 4296729. Applicant respectfully submits that Registrant did not file the requisite Declaration of Use and/or Excusable Nonuse under Section 8 prior to the expiration of the six-month grace period on September 5, 2019. As such, the registration will be cancelled in due course. Noting that no other objections have been raised, Applicant respectfully requests approval of the instant application for publication.